Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

NCT00418275 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Global Biotech